Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Molecular Carcinogenesis is Scopus-indexed (Q2, CiteScore 5.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Wiley-Liss Inc..
Checked against the index lists dated .
ISSN 0899-1987Verify ISSN ↗1098-2744Verify ISSN ↗
Publisher: Wiley-Liss Inc.
Cost to publish: About US$4,490 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Cancer Research | 107 / 233 | 54th | Q2 |
| Molecular Biology | 201 / 414 | 51st | Q2 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1988–present, best quartile Q2, CiteScore 5.6.
Molecular Carcinogenesis is Q2 in Cancer Research (rank 107 of 233) and Q2 in Molecular Biology (rank 201 of 414), by CiteScore 2025.
Molecular Carcinogenesis is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.6, which places it in quartile Q2 at the 54th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.048, quartile Q2, with an H-index of 114.
The publisher lists an article processing charge of about US$4,490 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Molecular Carcinogenesis is published by Wiley-Liss Inc. Its print ISSN is 0899-1987 and its online ISSN is 1098-2744.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Molecular Carcinogenesis has an h-index of 128 and a 2-year mean of 3.12 citations per paper (OpenAlex). Its Scopus CiteScore is 5.6, quartile Q2. On 2-year citations it ranks #88 of 229 Scopus journals in Cancer Research.
Molecular Carcinogenesis published 164 papers in 2025; its busiest recent year was 2024 with 208. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from China (63.2%), United States (18.5%) and India (7.4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 20 retracted papers are recorded (3.8 per 1,000 papers). The Problematic Paper Screener flags 1 of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.